Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

530
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
530
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

2.1K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postmyocardial infarction ventricular septal defect outcomes: Partial versus full presurgical hemodynamic support.

JTCVS open·2026
Same author

Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.

JACC. Cardiovascular interventions·2026
Same author

UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves: A Multicenter Study.

JACC. Cardiovascular interventions·2026
Same author

Impact of aortic root surgery during transcatheter aortic valve explant.

JTCVS structural and endovascular·2026
Same author

Iliac artery involvement determines optimal therapy in acute uncomplicated type B aortic dissection.

JTCVS structural and endovascular·2026
Same author

Endovascular arch repair using a novel single branch arch stent graft: 30-Day results from the chronic dissection arm of the NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness investigational device exemption study.

JTCVS structural and endovascular·2026

Related Experiment Video

Updated: Mar 14, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

677

Transcatheter Aortic Valve Replacement: Current Technology and Future Directions.

Richard C Gilmore1, Vinod H Thourani, Hanna A Jensen

  • 1From the Divisions of *Cardiothoracic Surgery and †Cardiology, Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, GA USA.

Innovations (Philadelphia, Pa.)
|September 24, 2016
PubMed
Summary

Transcatheter aortic valve replacement (TAVR) is a less invasive option for high-risk aortic stenosis patients. Ongoing technological advancements aim to minimize TAVR complications and improve outcomes.

More Related Videos

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.3K

Related Experiment Videos

Last Updated: Mar 14, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

677
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

3.3K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Aortic stenosis (AS) is a significant valvular heart disease.
  • Transcatheter aortic valve replacement (TAVR) is an alternative to surgical repair for high-risk AS patients.
  • TAVR offers a less invasive approach for surgically inoperable or high-risk individuals.

Purpose of the Study:

  • To review current technological advancements in TAVR.
  • To discuss the evolution of TAVR as a therapeutic option.
  • To highlight future directions in TAVR technology.

Main Methods:

  • Literature review of recent advancements in TAVR technology.
  • Analysis of technological improvements in valve structure, function, and delivery systems.
  • Synthesis of current data on TAVR efficacy and safety.

Main Results:

  • TAVR is increasingly utilized in high-risk patients with AS.
  • Technological progress has focused on reducing invasiveness and complications.
  • Advancements continue to expand TAVR's applicability.

Conclusions:

  • TAVR is a viable and evolving alternative for high-risk AS patients.
  • Continuous innovation in TAVR technology is crucial for patient outcomes.
  • Future research should focus on further refining TAVR devices and procedures.